Mougenot; Patrick

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mougenot; Patrick.The latest application filed is for "oxindole derivatives, preparation thereof and therapeutic use in the treatment of ampk-related diseases".

Company Profile

0.5.7

Mougenot; Patrick - Paris FR
Mougenot; Patrick - Antony FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases Grant 10,077,237 - Fett , et al. September 18, 2	2018-09-18
Oxindole Derivatives, Preparation Thereof And Therapeutic Use In The Treatment Of Ampk-related Diseases App 20160311770 - Fett; Eykmar ; et al.	2016-10-27
Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof Grant 8,546,391 - Fett , et al. October 1, 2	2013-10-01
Derivatives Of Oxadiazole And Pyridazine, Their Preparation And Their Application In Therapeutics App 20130137691 - FETT; Eykmar ; et al.	2013-05-30
Thiadiazole And Oxadiazole Derivatives, Preparation Thereof And Therapeutic Use Thereof App 20120040984 - Fett; Eykmar ; et al.	2012-02-16
Substituted quinoxalines, their preparation and their therapeutical use as 11.beta.HSD1 modulators Grant 7,947,834 - Braun , et al. May 24, 2	2011-05-24
Urea derivatives of tropane, their preparation and their therapeutic application Grant 7,897,773 - Aletru , et al. March 1, 2	2011-03-01
Urea Derivatives Of Tropane, Their Preparation And Their Therapeutic Application App 20100324084 - ALETRU; Michel ; et al.	2010-12-23
Novel Substituted Indazoles, The Preparation Thereof And Use Of Same In Therapeutics App 20100298377 - ALETRU; Michel ; et al.	2010-11-25
Derivatives Of Ureas Of Piperidine Or Pyrrolidine, Their Preparation And Their Therapeutical Use App 20090176775 - BRAUN; Alain ; et al.	2009-07-09
Urea Derivatives Of Tropane, Their Preparation And Their Therapeutic Application App 20090170894 - ALETRU; Michel ; et al.	2009-07-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.